Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

A study found people who took vitamin D supplements were less likely to develop dementia. But experts said other factors may ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

That gene therapy, known as 4D-125, was being studied in a phase 1/2 trial that enrolled 21 patients and was expected to read out next year, according to ClinicalTrials.gov. Roche walks away from ...

One report, for example, found that new dementia patients live an average of 6.7 years if they are diagnosed before age 70, and 2.6 years if they are diagnosed after age 90. Others peg the average ...

He also had Facebook.] In online support forums, caretakers of Alzheimer’s and dementia patients describe how their loved ones struggle to navigate the platforms they were once familiar with.